Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Share Market News
The Aussie dollar at a critical juncture and could turn fortunes for these ASX stocks
Share Market News
Top brokers name 3 ASX shares to sell today
⏸️ ASX Shares
Forget BrainChip (ASX:BRN) and buy and hold these outstanding ASX shares
Cheap Shares
2 dirt-cheap ASX shares I would buy today
Share Market News
Why the Cyclopharma (ASX:CYC) share price surged to record high today
⏸️ ASX Shares
Bolster your portfolio with these outstanding ASX blue chip shares
⏸️ ASX Shares
Forget day trading and get rich with these top ASX shares
Share Market News
Insiders have been buying Cochlear (ASX:COH) and this ASX share
⏸️ Investing
2 ASX shares I would buy again and one I regret
⏸️ ASX Shares
3 outstanding ASX shares to buy and hold for decades
Cheap Shares
3 ASX shares that are trading at bargain prices
Share Market News
Leading brokers name 3 ASX shares to sell today
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
